GILEAD SCIENCES, INC. 8-K

What Happened
Gilead Sciences, Inc. announced its financial results for the quarter and year ended December 31, 2025, in a press release dated February 10, 2026. The company presented results on both a U.S. GAAP basis and on a non-GAAP basis and filed the press release as Exhibit 99.1 to the Form 8-K. Management stated it uses non-GAAP measures for internal operating, budgeting and planning purposes and believes they are useful to investors when considered with GAAP results.

Key Details

• Filing: Form 8-K dated February 10, 2026, reporting results for the quarter and year ended December 31, 2025.
• Press release: Attached as Exhibit 99.1 to the 8-K.
• Accounting presentation: Results shown on both GAAP and non‑GAAP bases; reconciliations between GAAP and non‑GAAP appear on pages 11–14 of the press release.
• Disclosure note: The press release information included in the Form 8-K contains customary legal language regarding incorporation and Section 18 filing status.

Why It Matters
This filing signals Gilead’s latest quarterly and full‑year earnings and is the primary source for revenue, earnings, guidance and related metrics for investors. Because Gilead reports both GAAP and non‑GAAP results, investors should review the reconciliation provided to understand adjustments and compare performance consistently with prior periods and peers. For specific revenue, EPS or guidance changes, see the Exhibit 99.1 press release referenced in the 8‑K.